Top news of the week: 02.11.2021.
Biotechnology
Medicine
Antibody
Health care
Leukemia
Executive officer
Healthcare
Alnylam announces planned CEO transition of John Maraganore to Yvonne Greenstreet at year-end 2021: https://t.co/BJ811twqQ1
Open
Alnylam Announces Planned CEO Leadership Transition
Alnylam Pharmaceuticals Press Release | Oct 28, 2021
COVID-19 vaccine and cancer update 📰 A new study supports findings that COVID-19 vaccines may not be as effective in people with cancer – especially those with blood cancers – compared to people who don’t have cancer. Read more 👇
https://t.co/SpxpEGmcNB
Open
COVID-19 vaccine and cancer – latest updates
Recently, news of a COVID-19 vaccine has dominated headlines. We've summarised all the information that is out there, with rolling updates, in our new vaccine blog post.
27th Annual BIO-Europe® Digital executes its pivotal role in facilitating the flow of global life science deals
https://t.co/46BOyp3FEH
Openexecutes its pivotal role in facilitating the flow of global life science deals
Dear Sir or Madam, we would like to draw your attention to the following press release of EBD Group: 27th Annual BIO-Europe® Digital Munich, Germany – October 28, 2021: The highly …
RT @statnews: Ever wonder where the technology that created the Covid-19 vaccines came from?
Well, this is the story of mRNA: https://t.co/gilxviVnO2
Open
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Scientists have dreamed about the possibilities of custom-made messenger RNA. The pandemic may turn those possibilities into realilty.
Medpace Shares Rise 13% on Higher Q3 Earnings & Forward Outlook: https://t.co/Nv0RX63QzJ
$MEDP #medtech #stocks Medpace
Medpace
@WorkatMedpace https://t.co/tDP2teL0W9
OpenMedpace Shares Rise 13% on Higher Q3 Earnings & Forward Outlook
Shares of Medpace Holdings Inc. climbed to a new 52-week high after the CRO, a provider of full-service clinical trial development services, reported financial results for Q3/21 that ...